# Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.

> **NCT04877834** · PHASE1 · COMPLETED · sponsor: **University of Karachi** · enrollment: 60 (actual)

## Conditions studied

- Healthy
- Bioequivalence Study

## Interventions

- **DRUG:** Dexlansoprazole
- **DRUG:** Dexlansoprazole

## Key facts

- **NCT ID:** NCT04877834
- **Lead sponsor:** University of Karachi
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-18
- **Primary completion:** 2022-10-25
- **Final completion:** 2022-11-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04877834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04877834, "Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04877834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*